Severe HDL Cholesterol Reduction with Bempedoic Acid and Fenofibrate
New England Journal of Medicine · 27.03.2025 · 392 (12) · 1241-1242
DOI: 10.1056/nejmc2413726 ↗Kurz gefasst
Leserbrief in der Zeitschrift New England Journal of Medicine, erschienen am 27.03.2025. Verfasst von Francesco Sbrana und 2 weiteren Autor:innen. Beteiligte Einrichtung: Fondazione Toscana Gabriele Monasterio, Pisa, Italy. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 5 Literaturangaben.
Abstract (Originalsprache)
A reversible interaction between bempedoic acid and fenofibrate leading to a major, reversible decrease in HDL cholesterol levels was found in patients treated for nongenetic elevated LDL cholesterol levels.
Autor:innen und Institutionen
- Fondazione Toscana Gabriele Monasterio, Pisa, Italy.
ORCID-Profile: Francesco Sbrana
Zitieren
APA
Sbrana, F., Bigazzi, F., & Dal Pino, B. (2025). Severe HDL Cholesterol Reduction with Bempedoic Acid and Fenofibrate. New England Journal of Medicine, 392(12), 1241-1242. https://doi.org/10.1056/nejmc2413726
Vancouver
Sbrana F, Bigazzi F, Dal Pino B. Severe HDL Cholesterol Reduction with Bempedoic Acid and Fenofibrate. New England Journal of Medicine. 2025;392(12):1241-1242. doi:10.1056/nejmc2413726
BibTeX
@article{Sbrana2025,
author = {Sbrana, Francesco and Bigazzi, Federico and Dal Pino, Beatrice},
title = {Severe HDL Cholesterol Reduction with Bempedoic Acid and Fenofibrate},
journal = {New England Journal of Medicine},
year = {2025},
volume = {392},
number = {12},
pages = {1241--1242},
doi = {10.1056/nejmc2413726}
}
EUVIMED